Portfolio Companies 2026 for SV Health Investors: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
SV Health Investors accounts for 23 tracked companies with verified cap-table data, 23 of which disclose round sizes totalling $3.1B. The median disclosed raise is $95M, and the largest is AdvanCell at $440M, ahead of Bardy Diagnostics ($375M) and Quell Therapeutics ($344M).
The names that recur most often on these portfolio cap tables are SV Health Investors (23 companies), Bain Capital Life Sciences (3 companies), Jeito Capital (3 companies), Omega Funds (3 companies), Johnson & Johnson Innovation (3 companies), Sofinnova Partners (3 companies). By latest disclosed round, the market skews Series B (8), Series A (7), Series C (4), Series D (2).
Companies tracked: 23
Disclosed funding total: $3.1B across 23 companies
Median disclosed raise: $95M
Largest raise: AdvanCell — $440M
Stage mix: Series B 8 · Series A 7 · Series C 4 · Series D 2
